Noninvasive Monitoring of Programmed Death-Ligand 2 Expression with Positron Emission Tomography using 68Ga-labeled Peptide Antagonist in Preclinical and Exploratory Human Studies
1Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
2Department of Periodontology, Suzhou Stomatological Hospital, Suzhou, Jiangsu 215026, China.
3Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
4Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
5 National Clinical Research Center for Geriatric Disorders (Xiangya), Changsha 410008, China.
6Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha 410008, China.
收起